[1] |
Rhodes A, Evans LE, Alhazzani W. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016[J]. Crit Care Med,2017,45(3):486-552.
|
[2] |
Angus DC, vander Poll T. Severe sepsis and septic shock[J]. N Engl J Med,2013,369(9):840-851.
|
[3] |
Stevenson E, Rubenstein A, Radin G, et al. Two decades of mortality trends among patients with severe sepsis: a comparative Meta-analysis[J]. Crit Care Med,2014,42(3):625-631.
|
[4] |
Bodmann KF, Schenker M, Heinlein W, et al. Procalcitonin as a tool for the assessment of successful therapy of severe sepsis: An analysis using clinical routine data[J]. Med Klin Intensivmed Notfmed,2016,4:1-8.
|
[5] |
Arora S, Singh P, Singh PM, et al. Procalcitonin levels in survivors and nonsurvivors of sepsis: systematic review and Meta-analysis[J]. Shock,2015,43(3):212-221.
|
[6] |
Garcia-Alvarez M, Marik P, Bellomo R. Sepsis-associated hyperlactatemia[J]. Crit Care,2014,18(5):503.
|
[7] |
Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine[J]. Intensive Care Med,1996,22(7):707-710.
|
[8] |
Knaus WA, Draper EA, Wagner DP, et al. APACHEⅡ: a severity of disease classification system[J]. Crit Care Med,1985,13(10):818-829.
|
[9] |
中国医药教育协会. 感染相关生物标记物临床意义解读专家共识[J]. 中华结核和呼吸病杂志,2017,40(4):243-257.
|
[10] |
Prucha M, Bellingan G, Zazula R, et al. Sepsis biomarkers[J]. Clin Chim Acta,2015,440:97-103.
|
[11] |
Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis:clinical utility and limitations[J]. Crit Care Med,2008,36(3):941-52.
|
[12] |
Kern JW, Shoemaker WC. Meta-analysis of hemodynamic optimization in high-risk patients[J]. Crit Care Med,2002,30(8):1686-1692.
|
[13] |
王涛, 夏永富, 郝东, 等. 乳酸在脓毒性休克早期诊断及目标导向治疗中的意义[J]. 中华危重病急救医学,2014,26(1):51-55.
|
[14] |
Lokhandwala S, Moskowitz A, Lawniczak R, et al. Disease heterogeneity and risk stratification in sepsis-related occult hypoperfusion: A retrospective cohort study[J]. J Crit Care,2015,30(3):531-536.
|
[15] |
Jones AE, Shapiro NI, Trzeciak S, et al. Emergency medicine shock research network (EMShockNet) investigators. Lactate clearance vs. central venous oxygen saturation as goals of early sepsis therapy: A randomized clinical trial[J]. JAMA,2010,303:739-746.
|
[16] |
Montiel-Jarquin A, Lascarez-Lagunas I, Sanchez-Gasca L, et al. Lactate clearance is a prognostic factor in patients on shock state[J]. Eur J Gen Med,2012,9(2):98-103.
|
[17] |
Saini N, Malhotra A, Chhabra S, et al. Methylmalonic academia mimicking diabetic ketoacidosis and septic shock in infants[J]. Indian Crit Care Med,2015,19(3):183-185.
|
[18] |
胡雪忠, 孙勤, 徐伟华. 等血清PCT与PCT清除率在呼吸机相关性肺炎感染疗效及预后的评估价值[J]. 中华医院感染学杂志,2017,27(24):5580-5583.
|
[19] |
丁佳, 皋源. PCT清除率与△SOFA在复杂腹腔感染中的预测价值[J]. 实用医学杂志,2016,32(24):4034-4037.
|
[20] |
包磊, 张敏, 颜培夏. 等.动脉血乳酸及其清除率预测感染性休克患者预后的回顾性研究[J]. 中华危重病急救医学,2015,27(1):35-42.
|